Incidence of Autoimmunity in Patients (pts) with Low-Risk (LR) Myelodysplastic Syndrome (MDS): 10 Years Follow-up

被引：2
|
作者：
Elkhanany, Ahmed [1 ]
Hanson, Curtis A. [1 ]
Patnaik, Mrinal [1 ]
Elliott, Michelle [1 ]
Litzow, Mark [1 ]
Al-Kali, Aref [1 ]
机构：
[1] Mayo Clin, Div Hematopathol, Rochester, MN USA
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.4931.4931
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4931
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Phase 2 randomised trial, repurposing Danazol and VBaP in low-risk myelodysplastic syndrome: REPAIR MDS
    Raghavan, Manoj
    Jenkins, Stephen
    Wintrich, Sophie
    Drayson, Mark
    Bunce, Chris
    Culligan, Dominic
    Kulasekararaj, Austin
    Wiseman, Dan
    Foster, Bethany
    Dunn, Janet
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 : 153 - 153
  • [42] Phase 2 randomised trial, repurposing Danazol and VBaP in low-risk myelodysplastic syndrome: REPAIR MDS
    Raghavan, Manoj
    Jenkins, Stephen
    Wintrich, Sophie
    Drayson, Mark
    Bunce, Chris
    Culligan, Dominic
    Kulasekararaj, Austin
    Wiseman, Dan
    Foster, Bethany
    Dunn, Janet
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 : 153 - 153
  • [43] Delayed response to lenalidomide in International Prognostic Scoring System (IPSS) low-risk myelodysplastic syndrome (MDS)
    Garcia, A. Mejia
    Asija, A.
    Besa, E. C.
    Giagounidis, A.
    Fonseca, G. A.
    LEUKEMIA RESEARCH, 2013, 37 : S111 - S111
  • [44] Identification and Optimal Postsurgical Follow-Up of Patients with Very Low-Risk Papillary Thyroid Microcarcinomas
    Durante, Cosimo
    Attard, Marco
    Torlontano, Massimo
    Ronga, Giuseppe
    Monzani, Fabio
    Costante, Giuseppe
    Ferdeghini, Marco
    Tumino, Salvatore
    Meringolo, Domenico
    Bruno, Rocco
    De Toma, Giorgio
    Crocetti, Umberto
    Montesano, Teresa
    Dardano, Angela
    Lamartina, Livia
    Maniglia, Adele
    Giacomelli, Laura
    Filetti, Sebastiano
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (11): : 4882 - 4888
  • [45] The Worcestershire Breast Cancer Survivorship Programme: A New Program for Follow-Up of Low-Risk Patients
    Goonewardene, Sandria
    Thrush, S.
    BREAST JOURNAL, 2014, 20 (04): : 437 - 439
  • [46] Effect of Luspatercept on Biomarkers of Erythropoiesis in Patients (Pts) with Lower-Risk Myelodysplastic Syndromes (LR-MDS) in the Medalist Trial
    Platzbecker, Uwe
    Zhu, Yiming
    Ha, Xianwei
    Risueno, Alberto
    Chan, Esther
    Zhang, George
    Dunshee, Diana R.
    Acar, Melih
    Shetty, Jeevan K.
    Ito, Rodrigo
    MacBeth, Kyle
    Santini, Valeria
    Garbowski, Maciej W.
    Fenaux, Pierre
    Schwickart, Martin
    BLOOD, 2020, 136
  • [47] Correlates of survival in hemodialysis (HD) patients (PTS): 12 years of follow-up
    Avram, M.M.
    Mittman, N.
    Sreedhara, R.
    Henry, A.
    Chattopadhyay, J.
    ASAIO Journal, 2000, 46 (02)
  • [48] Simultaneous pancreas and kidney transplantation: incidence and risk factors for amputation after 10 years follow-up
    Mac Craith, E.
    Davis, N. F.
    Browne, C.
    Mohan, P.
    Hickey, D.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 : S134 - S134
  • [49] HEMATOPOIETIC GROWTH-FACTOR THERAPY FOR PATIENTS WITH MYELODYSPLASIA AT LOW-RISK FOR LEUKEMIA (MDS-LR)
    WILLEMZE, R
    BRITISH JOURNAL OF HAEMATOLOGY, 1992, 82 (01) : 236 - 236
  • [50] Follow-up analysis and research of very low-risk and low-risk gastrointestinal stromal tumors after endoscopic resection
    Gao, Jiaxin
    Liu, Zide
    Liu, Xingxing
    Shu, Xu
    Zhu, Yin
    Chen, Youxiang
    Zeng, Chunyan
    SCIENTIFIC REPORTS, 2024, 14 (01):
12345